Literature DB >> 25375258

Complete stereochemistry and preliminary structure-activity relationship of rakicidin A, a hypoxia-selective cytotoxin from Micromonospora sp.

Naoya Oku1, Shouhei Matoba, Yohko Momose Yamazaki, Ryoko Shimasaki, Satoshi Miyanaga, Yasuhiro Igarashi.   

Abstract

The complete stereochemistry of rakicidin A, a hypoxia-selective cytotoxin produced by Micromonospora sp., was unambiguously established by extensive chemical degradation and derivatization studies. During the PGME derivatization-based configurational analysis of 3-hydroxy-2,4,16-trimethylheptadecanoic acid, an irregular Δδ distribution was observed, which necessitated further acylation of the 3-hydroxy group to resolve the inconsistency. A hydrogenated derivative of rakicidin A, its ring-opened product, and two congeners with different alkyl chain lengths were tested for hypoxia-selective cytotoxicity. The results indicated that both the conjugated diene unit and appropriate chain length are essential for the unique activity of rakicidin A.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25375258     DOI: 10.1021/np500276c

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  9 in total

1.  Synthesis of ent-BE-43547A1 reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural products.

Authors:  Nikolaj L Villadsen; Kristian M Jacobsen; Ulrik B Keiding; Esben T Weibel; Bjørn Christiansen; Thomas Vosegaard; Morten Bjerring; Frank Jensen; Mogens Johannsen; Thomas Tørring; Thomas B Poulsen
Journal:  Nat Chem       Date:  2016-11-21       Impact factor: 24.427

Review 2.  The genus Micromonospora as a model microorganism for bioactive natural product discovery.

Authors:  Mohamed S Hifnawy; Mohamed M Fouda; Ahmed M Sayed; Rabab Mohammed; Hossam M Hassan; Sameh F AbouZid; Mostafa E Rateb; Alexander Keller; Martina Adamek; Nadine Ziemert; Usama Ramadan Abdelmohsen
Journal:  RSC Adv       Date:  2020-06-08       Impact factor: 4.036

3.  Rakicidin F, a new antibacterial cyclic depsipeptide from a marine sponge-derived Streptomyces sp.

Authors:  Shigeru Kitani; Tatsuya Ueguchi; Yasuhiro Igarashi; Kantinan Leetanasaksakul; Arinthip Thamchaipenet; Takuya Nihira
Journal:  J Antibiot (Tokyo)       Date:  2017-08-02       Impact factor: 2.649

4.  Draft genome sequence of Micromonospora sp. DSW705 and distribution of biosynthetic gene clusters for depsipeptides bearing 4-amino-2,4-pentadienoate in actinomycetes.

Authors:  Hisayuki Komaki; Natsuko Ichikawa; Akira Hosoyama; Moriyuki Hamada; Enjuro Harunari; Arisa Ishikawa; Yasuhiro Igarashi
Journal:  Stand Genomic Sci       Date:  2016-10-22

5.  Draft genome sequence of Streptomyces sp. MWW064 for elucidating the rakicidin biosynthetic pathway.

Authors:  Hisayuki Komaki; Arisa Ishikawa; Natsuko Ichikawa; Akira Hosoyama; Moriyuki Hamada; Enjuro Harunari; Takuya Nihira; Watanalai Panbangred; Yasuhiro Igarashi
Journal:  Stand Genomic Sci       Date:  2016-10-21

6.  1,10-Secoguaianolides from Artemisia austro-yunnanensis and Their Anti-Inflammatory Effects.

Authors:  Lan Liu; Weifeng Dai; Cheng Xiang; Jun Chi; Mi Zhang
Journal:  Molecules       Date:  2018-07-05       Impact factor: 4.411

7.  Diversity, Bioactivity Profiling and Untargeted Metabolomics of the Cultivable Gut Microbiota of Ciona intestinalis.

Authors:  Caroline Utermann; Vivien A Echelmeyer; Ernest Oppong-Danquah; Martina Blümel; Deniz Tasdemir
Journal:  Mar Drugs       Date:  2020-12-24       Impact factor: 5.118

Review 8.  Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review.

Authors:  Yadollah Bahrami; Sasan Bouk; Elham Kakaei; Mohammad Taheri
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

Review 9.  Recent Achievements in Total Synthesis for Integral Structural Revisions of Marine Natural Products.

Authors:  Min Woo Ha; Jonghoon Kim; Seung-Mann Paek
Journal:  Mar Drugs       Date:  2022-02-25       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.